Literature DB >> 1303479

The role of prophylactic antibiotics in caesarean section--a randomised trial.

N K Ng1, N Sivalingam.   

Abstract

A prospective randomised controlled study was conducted over a 6 month period on the value of administering prophylactic antibiotics in patients undergoing emergency caesarean section at the Ipoh General Hospital. A total of 222 patients were randomised to receive 24 hours of ampicillin (500 mg per dose), cefoperazone (1 gm per dose) or no antibiotics. In all parameters of patient morbidity, the group receiving cefoperazone showed significantly better results as compared to the group not receiving antibiotics. The ampicillin group also had favourable results but generally not achieving statistical significance. Prophylactic antibiotics appear to be beneficial and consideration should be given to make it a routine in all emergency caesarean sections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1303479

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  5 in total

Review 1.  Different classes of antibiotics given to women routinely for preventing infection at caesarean section.

Authors:  Gillian M I Gyte; Lixia Dou; Juan C Vazquez
Journal:  Cochrane Database Syst Rev       Date:  2014-11-17

Review 2.  Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Authors:  Fiona M Smaill; Rosalie M Grivell
Journal:  Cochrane Database Syst Rev       Date:  2014-10-28

Review 3.  Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Authors:  Fiona M Smaill; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

4.  Different classes of antibiotics given to women routinely for preventing infection at caesarean section.

Authors:  Myfanwy J Williams; Carolina Carvalho Ribeiro do Valle; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2021-03-04

5.  Surgical-site Infection Following Cesarean Section in Kano, Nigeria.

Authors:  Ta Jido; Id Garba
Journal:  Ann Med Health Sci Res       Date:  2012-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.